TAMPA, FL / ACCESSWIRE / December 8, 2023 / MEDFINITI B.V. and its U.S. subsidiaries, MEDFINITI, Inc. and HemWell MD LLC, are excited to announce the introduction of HemWell, a revolutionary electrosurgical medical device which transforms the approach to hemorrhoid treatment. This state-of-the-art device is engineered to provide a minimally invasive, pain-free solution, marking a significant leap forward in patient care and experience.
HemWell is uniquely designed to address the needs of millions suffering from hemorrhoids. It offers a seamless and comfortable treatment experience, minimizing the discomfort and recovery time often associated with traditional methods.
“Developing HemWell was a journey driven by our commitment to patient wellness and the pursuit of better healthcare solutions,” said Michael Goeree, Founder & Chairman of MEDFINITI. “Our device is not just an advancement in technology; it’s a new hope for those suffering from this common yet often overlooked condition.”
Dr. Stephen Goldman, MD, Chief Medical Officer at MEDFINITI, added, “The success stories we’ve witnessed with HemWell are a testament to our dedication. We’re bringing a much-needed change to hemorrhoid treatment, focusing on patient comfort and efficacy.”
The patented and FDA-approved (USA) and soon CE-MDR-approved (Europe) HemWell is designed for ease of use and effectiveness, reducing the need for invasive procedures. Its innovative technology targets the problem at its source, ensuring a faster and more comfortable recovery and all-round better patient experience.
MEDFINITI invites healthcare professionals and patients to discover more about HemWell and its benefits. For investor information about MEDFINITI and/or HemWell, further information just about HemWell, or to schedule a HemWell demonstration, please contact:
Ms. Jennifer Ellerman, HemWell MD LLC
Phone: +1-813-775-6171
Email: info@hemwellmd.com
Websites: www.hemwellmd.com, www.hemwellrelief.com, www.hemwell.info, www.medfiniti.com
SOURCE: Medfiniti B.V.
View the original press release on accesswire.com
NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…
AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…
Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…
Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…
Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…
Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…